Robert Matney

Opinions=mine. NatSec/Defense tech @primer_ai. Art+tech @thehiddenroom & @FuseboxFestival. Alum of @apple, Yonder, others. Shkspr lvr. Cancer survivor. Curious.

[Ankur Nagpal @ankurnagpal]

Looking for a venue in NYC to host a fireside chat for 100-200 people next week

DM me or @andruyeung if you have something that could work

Dinner / drinks on us if you help us source something 👀

[Robert Matney @rmatney]

@alixabeth Strong agree on the weakness of the frame.

[Tim Mak @timkmak]

Anyone have friends in Yerevan, Armenia? Asking for a story.

If not, will you repost for signal boost?

[Code for Africa @Code4Africa]

🤖 Did you just read a pointed AI-generated article?

OpenAI has just exposed an account generating synthetic geopolitical commentary about Africa and laundering it in African news outlets.

🔗 Read more here: https://t.co/7y6vNLIhaM

[Will Manidis @WillManidis]

https://t.co/bDCdltFo0A

[Robert Matney @rmatney]

@bznotes Gentle condolences to you and those who loved him.

[Robert Matney @rmatney]

The world is watching your cruelty, @Aetna.

[chad burner @BootleggedChad]

4 days out from my life-changing surgery, @Aetna has denied the appeal for my brain surgery.

to be clear, when i signed up to aetna months ago, the coordinator had confirmed they would cover this surgery. then, a week ago, they said the surgery was too experimental/elective and denied coverage. we appealed. that appeal was just denied today.

now, my neurosurgeon is trying to do a peer-to-peer consult with someone at aetna to explain why i need it so we don’t lose the surgery date on monday morning. aetna is not being responsive.

this is sadistic and a violation of basic trust. please spread this so they can’t ignore it. they may not care if i live or die but people should know just what kind of company they’re dealing with. and please pray they are able to have a peer-to-peer consult with my neurosurgeon and have a change of heart.

[Robert Matney @rmatney]

Having spent a painful amount of time running semantic and cultural data analysis of deep web, can confirm these two videos are accurate.

[Claude Taylor @TrueFactsStated]

Do we need to move away from the Right vs Left framing? Here are two important and informative videos.

[Emily Ramshaw @eramshaw]

@19thnews is hiring an audience growth manager! Apply today to collaborate across departments and develop and execute an audience growth strategy to reach the women and LGBTQ+ people we aim to serve. Deadline: September 9.

https://t.co/DX2aviR7Yv

[Robert Matney @rmatney]

@bznotes Not yet enough (is always and ever the only honest answer)

[Robert Matney @rmatney]

@JoshuaBaer @EugeneAustin @CapitalFactory Aligns it as well to the smart work being done by SCSP AI Expo. Carter made such an impact - honoring it matters.

[Robert Matney @rmatney]

@EugeneAustin @JoshuaBaer @CapitalFactory (See you both this week at FSN)

[Robert Matney @rmatney]

@EugeneAustin @JoshuaBaer @CapitalFactory Aiming high: a SCIF as a service would be nice.

[Robert Matney @rmatney]

@yishan Thanks for sharing. I’ve cross posted to creative community.

[Yishan @yishan]

If you know someone, send them this job!

https://t.co/nYaTW1o09h

[Robert Matney @rmatney]

AI colleagues - dig into this research paper!

The possibilities are breathtaking. We mustn’t let other AI topics consume all oxygen in room - medical innovation is a plausible superpower.

[disclaimer: @PatrickHwuMD, now CEO of Moffit, was formerly my doctor at MD Anderson]

[Dr. Patrick Hwu @PatrickHwuMD]

#ScienceSaturday

❓ Can AI help us engineer better cancer therapies, one protein at a time?

➡️ A new study in Science reveals how generative AI is being used to rapidly create de novo protein minibinders to target cancer-associated peptide–MHC complexes (pMHCs), which are key triggers for T cell activation.

➡️ Using tools like RFdiffusion, AlphaFold2, and ProteinMPNN, researchers engineered minibinders that mimic T cell receptors and bind to tumor-specific pMHC targets like NY-ESO-1. When incorporated into CARs, these AI-designed molecules enabled T cells to kill #melanoma cells in lab experiments.

🌟 This approach could streamline and personalize T cell therapies, especially in cancers where conventional TCR discovery is too slow or difficult. It opens a path to designing synthetic proteins in weeks, not years, with built-in specificity and potency.

🔗 Read more in @ScienceMagazine: https://t.co/35lXkW2QWJ

@TimothyPJenkins @KrisHaurum @DTUtweet @DTUbioengineer

#CancerResearch #AI #Immunotherapy #CancerImmunotherapy

[Robert Matney @rmatney]

@fotsch1 @adcock_brett @adcock_colby @dickclucas I mean, I think you just named the first episode: “Through the PRoof”

[Robert Matney @rmatney]

Slava Ukraini! #SlavaUkraini

[Bilal Zuberi @bznotes]

General Tony Thomas (T2 to those who know him - @TonyT2Thomas) never stops caring for men and women in uniform, and their children.

Pls support him as he rides 406 miles on his bike to raise money for the SPECIAL OPERATIONS WARRIOR FOUNDATION (SOWF).

Link below.